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MDA-7/IL-24 has noteworthy potential as an anticancer thera-
peutic because of its diversity of antitu-
mor properties, its lack of toxicity toward 
normal cells and tissues, and its safety 
and efficacy as evidenced in a phase I 
clinical trial. In a recent study, we docu-
ment that Ad.mda-7-induced ER stress 
and ceramide production leads to early 
autophagy that subsequently switches to 
apoptosis in human prostate cancer cells. 
During the apoptotic phase, the MDA-7/
IL-24 protein physically interacts with 
Beclin 1 and this interaction might 
inhibit Beclin 1 function culminating in 
apoptosis. Conversely, Ad.mda-7 infec-
tion leads to calpain-mediated cleav-
age of the Atg5 protein that might also 
facilitate a biochemical switch from auto-
phagy to apoptosis. Our recent paper 
reveals novel aspects of the interplay 
between autophagy and apoptosis that 
underlie the cytotoxic action of MDA-7/
IL-24 in prostate cancer cells. These 
new insights into MDA-7/IL-24 action 
provide intriguing leads for developing 
innovative combinatorial approaches for 
prostate cancer therapy.
Ad.mda-7 induces autophagy selec-
tively in different types of human pros-
tate cancer cells, without promoting 
this effect in immortal normal human 
prostate epithelial cells. We document 
that Ad.mda-7-induced ER stress and 
ceramide generation result in induction of 
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autophagy in prostate cancer cells, with-
out affecting normal human prostate epi-
thelial cells, via the canonical autophagic 
pathway, involving BECN1, ATG5 and 
hVPS34.
MDA-7/IL-24 induces ER stress and 
ceramide production and these changes 
play a pivotal role in autophagy induc-
tion (Fig. 1). We examined the effect 
of the ER stress inhibitor salubrinal 
and the ceramide inhibitor ISP-1 on 
Ad.mda-7-induced autophagy by analyz-
ing LC3-II accumulation 24 h postinfec-
tion. Co-treatment of Ad.mda-7-infected 
DU-145 cells with noncytotoxic doses 
Figure 1. model illustrating the possible 
molecular mechanism of ER stress- and 
ceramide-mediated autophagy promoted 
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MDA-7/IL-24 might inhibit autophagy. 
To determine the role of ATG5 in the 
predominantly apoptotic phase at 48 h 
post-Ad.mda-7 infection, ATG5 mRNA 
and protein expressions were analyzed. 
At 48 h, Ad.mda-7 infection results in 
significant induction in ATG5 mRNA 
levels. Although the levels of the ATG5 
protein do not significantly change upon 
Ad.mda-7 infection, a second band cor-
responding to a molecular weight 24-kDa 
protein is observed in Ad.mda-7-infected 
cells. Considering this finding, calpain 
activity was measured in Ad.mda-7-
treated cells by calpain-Glo protease assay. 
Calpain activity is significantly higher in 
Ad.mda-7-infected cells when compared 
with control or Ad.vec-infected cells. Our 
study suggests a novel role for Beclin 1 and 
ATG5 in mediating a switch between pro-
tective autophagy and apoptosis in pros-
tate cancer cells infected with Ad.mda-7. 
Based on our recent observations, employ-
ing strategies to block autophagy through 
promoting ER stress and ceramide pro-
duction may represent a viable tactic 
for enhancing the antitumor activity of 
mda-7/IL-24 toward prostate and poten-
tially other cancers.
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indicated that inhibition of autophagy can 
sensitize prostate tumor cells to the cyto-
toxic (apoptotic) actions of MDA-7/IL-24 
and Ad.mda-7-induced autophagy might 
initially be a cytoprotective mechanism 
in prostate tumor cells. Additionally, the 
connection between Ad.mda-7-induced 
autophagy and apoptosis was investigated 
using Bcl-2 and Bcl-x
L
-overexpressing 
DU-145 cells (DU-Bcl-2 and DU-Bcl-x
L
). 
Ad.mda-7-infected DU-Bcl-2 and 
DU-Bcl-x
L
 cells continue to exhibit higher 
autophagic phenotypes as compared with 
control DU-Neo clones, indicating that 
in DU-145 cells, Ad.mda-7-induced auto-
phagy culminates in apoptosis, and when 
apoptosis is blocked by overexpression of 
Bcl-2 or Bcl-x
L
 autophagy increases. To 
further confirm this possibility, we stained 
Ad.mda-7-infected DU-145 cells with 
MDC and PI and analyzed treated-cells 
by flow cytometry 48 h post-infection. 
We observed that autophagic cells also 
display apoptotic features as revealed by 
both MDC and PI staining in 25.8% of 
Ad.mda-7-infected cells as compared with 
1.9% of Ad.vec-infected cells.
To investigate the role of the autoph-
agy-related genes BECN1 and ATG5 in 
Ad.mda-7-induced apoptosis, we knocked 
down BECN1 and ATG5 expression with 
siRNA in DU-145 cells and examined 
Ad.mda-7 sensitivity. Beclin 1-deficient 
DU-145 cells exhibit increased sensitiv-
ity toward Ad.mda-7 when administered 
at 100 pfu/cell. In contrast, silencing of 
the ATG5 gene results in only a partial 
resistance to Ad.mda-7. These findings 
suggest that although at 24 h post-infec-
tion, Ad.mda-7 induces Beclin 1 and 
ATG5 to facilitate autophagy, at 48 h 
there might be inhibition of Beclin 1 and 
augmentation of ATG5 that then leads 
to apoptosis. During this predominantly 
apoptotic phase of Ad.mda-7-treatment 
the interaction between Beclin 1 and 
of salubrinal (5 μM) or ISP-1 (10 μM) 
significantly inhibit LC3-II accumula-
tion, and a combination of salubrinal and 
ISP-1 further reduce Ad.mda-7-induced 
LC3-II accumulation. The three major 
transducers of ER stress are IRE1, PERK 
and ATF6, which all sense the presence of 
unfolded proteins and transduce signals 
to the nucleus or cytosol. We hypoth-
esized that one or more of these transduc-
ers must activate the signaling required 
for Ad.mda-7-induced autophagy and 
tested this possibility using siRNA target-
ing IRE1 and ATF6, and with a PERK 
dominant negative mutant. Among these 
treatments, IRE1 and ATF6 knockdown 
cells show no change in GFP-LC3-II 
accumulation during a 24 h period after 
Ad.mda-7 infection. However, Ad.mda-7 
induces punctate staining of GFP-LC3 
vacuoles and a dominant negative inhibi-
tor of PERK (Dn-PERK) significantly 
inhibits LC3-II accumulation in DU-145 
cells. These results suggest a potential 
involvement of PERK, an ER stress medi-
ator, in Ad.mda-7-induced autophagy. 
Collectively, these observations support 
the hypothesis that Ad.mda-7-induced 
ER stress and ceramide production might 
contribute to autophagy through a PERK-
dependent pathway in prostate carcinoma 
cells.
Cellular stress can promote autophagy 
and apoptosis in a number of ways includ-
ing induction of autophagy/apoptosis 
sequentially, simultaneously, or in a mutu-
ally exclusive manner. Electron micros-
copy studies document autophagic features 
at 24 h followed by apoptotic features at 
48 h post-Ad.mda-7 infection in DU-145 
cells. To investigate the potential relation-
ship between autophagy and apoptosis, we 
analyzed the growth inhibitory potential 
of Ad.mda-7 in DU-145 cells in the pres-
ence of the autophagy inhibitor 3-meth-
yladenosine (3-MA). This experiment 
